Next »
American Journal of Ophthalmology
Volume 137, Issue 2
, Pages 219-227
, February 2004
The confocal scanning laser ophthalmoscopy ancillary study to the ocular hypertension treatment study: study design and baseline factors
References
- . The Ocular Hypertension Treatment Study (design and baseline description of the participants). Arch Ophthalmol. 1999;117:573–583
-
Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:714–720; discussion 829–830
-
Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:701–713; discussion 829–830
- . Confirmation of visual field abnormalities in the Ocular Hypertension Treatment Study. Ocular Hypertension Treatment Study Group. Arch Ophthalmol. 2000;118:1187–1194
- Baseline visual field characteristics in the ocular hypertension treatment study. Ophthalmology. 2002;109:432–437
- The Ocular Hypertension Treatment Study (reproducibility of cup/disk ratio measurements over time at an optic disc reading center). Am J Ophthalmol. 2002;133:19–28
- . Effect of repetitive imaging on topographic measurements of the optic nerve head. Arch Ophthalmol. 1993;111:636–638
- . Test-retest variability of topographic measurements with confocal scanning laser tomography in patients with glaucoma and control subjects. Am J Ophthalmol. 1994;118:9–15
- . Regional test-retest variability of confocal scanning laser tomography. Am J Ophthalmol. 1995;120:433–440
- . Optic nerve head topography in ocular hypertensive eyes using confocal scanning laser ophthalmoscopy. Am J Ophthalmol. 1996;122:520–525
- . A comparison of healthy, ocular hypertensive, and glaucomatous optic disc topographic parameters. J Glaucoma. 1997;6:363–370
- Imaging of the optic disc and retinal nerve fiber layer (the effects of age, optic disc area, refractive error, and gender). J Opt Soc Am A Opt Image Sci Vis. 2002;19:197–207
- . Detection of early glaucomatous structural damage with confocal scanning laser tomography. J Glaucoma. 1998;7:121–127
-
.
Ability of the Heidelberg Retina Tomograph to detect early glaucomatous visual field loss.
J Glaucoma. 1995;4:242–247
- . Agreement between clinicians and a confocal scanning laser ophthalmoscope in estimating cup/disk ratios. Am J Ophthalmol. 1995;119:415–421
-
Pinherio JC, Bates DM. Mixed-effects models in S and S-plus. New York: Springer-Verlag, 2000
-
.
A language for data analysis and graphics.
J Computat Graphic Stat. 1996;5:299–314
-
.
A simple sequentially rejective multiple test procedure.
Scand J Stat. 1979;6:65–70
-
Zangwill LM, Weinreb RN, Berry CC, et al. Racial differences optic disc topography: in baseline results from the confocal scanning laser ophthalmoscopy ancillary study to the Ocular Hypertension Treatment Study. Arch Ophthalmol 2003; forthcoming
- . Agreement in assessing optic discs with a digital stereoscopic optic disc camera (Discam) and Heidelberg retina tomograph. Br J Ophthalmol. 2002;86:196–202
- . Comparison between tomographic scanning evaluation and photographic measurement of the neuroretinal rim. Am J Ophthalmol. 1996;121:494–501
- . Comparison of measurements of neuroretinal rim area between confocal laser scanning tomography and planimetry of photographs. Br J Ophthalmol. 1998;82:362–366
- . Scanning laser tomography to evaluate optic discs of normal eyes. Jpn J Ophthalmol. 1999;43:410–414
- . Aging changes of the optic nerve head in relation to open angle glaucoma. Br J Ophthalmol. 1997;81:840–845
- . Correlation of blue-on-yellow visual fields with scanning confocal laser optic disc measurements. Invest Ophthalmol Vis Sci. 1997;38:2452–2459
- . Hemifield association between blue-on-yellow visual field and optic nerve head topographic measurements. Graefes Arch Clin Exp Ophthalmol. 1998;236:339–345
- Association between quantitative nerve fiber layer measurement and visual field loss in glaucoma. Am J Ophthalmol. 1995;120:732–738
- . Quantitative differences between the optic nerve head and peripapillary retina in low-tension and high-tension primary open-angle glaucoma. Am J Ophthalmol. 1997;124:805–813
-
.
Correlation of peripapillary retinal height and visual field in glaucoma and normal subjects.
J Glaucoma. 1995;4:110–116
- . Optic disk topography after medical treatment to reduce intraocular pressure. Am J Ophthalmol. 2000;130:280–286
- . Change in optic disk topography after trabeculectomy. Am J Ophthalmol. 1996;122:690–695
- Longitudinal changes in optic disc topography of adult patients after trabeculectomy. Ophthalmology. 1999;106:1147–1151
- Reversal of optic disc cupping after glaucoma surgery analyzed with a scanning laser tomograph. Ophthalmology. 1999;106:1013–1018
- Discriminating between normal and glaucomatous eyes using the Heidelberg Retina Tomograph, GDx nerve fiber analyzer, and optical coherence tomograph. Arch Ophthalmol. 2001;119:985–993
- . The effect of optic disc size on diagnostic precision with the Heidelberg Retina Tomograph. Ophthalmology. 1997;104:545–548
- Interobserver variability of optic disc variables measured by confocal scanning laser tomography. Am J Ophthalmol. 2000;132:57–62
☆ This study was supported by Grants EY11158, EY09341, and EY09307 from the National Eye Institute and the National Center of Minority Health and Health Disparities, National Institutes of Health, Bethesda, Maryland; Merck Research Laboratories, White House Station; and by an unrestricted grant from Research to Prevent Blindness, New York, New York. The authors have received support from the following companies: R.N.Weinreb: consultant or honoraria from Alcon and Novartis; consultant or honoraria and grant support or patent received/pending from Allergan Therapeutics, Heidelberg Engineering, Humphrey Instruments, Merck Research Laboratories, and Pharmacia/Upjohn; owns stock in Merck. J. M. Liebmann: consultant or honoraria from Allergan Therapeutics, Heidelberg Engineering, Novartis, and Pharmacia/Upjohn. J. D. Brandt: consultant or honoraria from Allergan, Merck, and Pharmacia/Upjohn. G. A. Cioffi: consultant or honoraria from Merck, Alcon Laboratories; consultant or honoraria and grant support/patent from Allergan, Ciba Vision, Heidelberg Engineering, Humphrey Instruments, Novartis, and Pharmacia/Upjohn. A. L. Coleman: grant support from Alcon Laboratories, consultant or honoraria from Allergan Therapeutics and Pharmacia/Upjohn. J. R. Piltz-Seymour: consultant or honoraria from Alcon, Allergan, Merck, and Pharmacia/Upjohn. M. A. Kass: consultant or honoraria from Merck and Pharmacia/Upjohn. L. M. Zangwill: research support (equipment) from Heidelberg Engineering, Laser Diagnostic Technologies, and Carl Zeiss Meditec.
PII: S0002-9394(03)00969-3
doi: 10.1016/j.ajo.2003.08.031
© 2003 Elsevier Inc. All rights reserved.
Next »
American Journal of Ophthalmology
Volume 137, Issue 2
, Pages 219-227
, February 2004
